Individualized Pharmaceutical-care in Outpatients With Cancer Pain

University of Chinese Academy Sciences

Status: Unknown

Conditions: Cancer Pain

Treatments: Other: Pharmaceutical care

Study type: Interventional

Funder types: Other

Identifiers

NCT03439904

ECCOPG-003

Details and patient eligibility

About

The purpose of the study is to investigate the impact of pharmaceutical care on cancer pain treatment for opioid-tolerant outpatients

Full description

This study is a prospective multicenter randomized controlled study to investigate the impact of pharmaceutical care on cancer pain treatment for opioid-tolerant outpatients treated with sustained released morphine, oxycodone, and transdermal fentanyl.

Enrollment: 200 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients aged 18 years or older;
• Histologically confirmed solid tumor;
• Diagnosed chronic cancer pain;
• Opioid-tolerant patients;
• Overall survival is expected to be over 3 months;
• Karnofsky performance score≥50;
• Willing and able to comply with the protocol

Exclusion criteria

• Patients aged 18 years or older;
• Histologically confirmed solid tumor;
• Diagnosed chronic cancer pain;
• Opioid-tolerant patients;
• Overall survival is expected to be over 3 months;
• Karnofsky performance score≥50;
• Willing and able to comply with the protocol

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

200 participants in 2 patient groups

pharmaceutical care intervention group

Experimental group

Description:

Patients will receive individualized pharmaceutical care in addition to usual medical care

Treatment:

Other: Pharmaceutical care

control group

No Intervention group

Description:

Patients will receive usual medical care